Your browser doesn't support javascript.
loading
Neuroprotective effect of quercetin and nano-quercetin against cyclophosphamide-induced oxidative stress in the rat brain: Role of Nrf2/ HO-1/Keap-1 signaling pathway.
AbdElrazek, Dina A; Ibrahim, Marwa A; Hassan, Neven H; Hassanen, Eman I; Farroh, Khaled Y; Abass, H I.
Afiliação
  • AbdElrazek DA; Physiology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
  • Ibrahim MA; Biochemistry Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. Electronic address: marwaibrahim@cu.edu.eg.
  • Hassan NH; Physiology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
  • Hassanen EI; Pathology Department, Faculty of Veterinary Medicine, Cairo University, Egypt.
  • Farroh KY; Nanotechnology and Advanced Materials Central Lab, Agricultural Research Center, Giza, Egypt.
  • Abass HI; Physiology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Neurotoxicology ; 98: 16-28, 2023 09.
Article em En | MEDLINE | ID: mdl-37419146
Quercetin (Qu) is a powerful flavanol antioxidant that is naturally found in plants and is part of the flavonoid family. Qu has a wide range of biological properties, such as neuroprotective, anti-cancer, anti-diabetic, anti-inflammatory, and radical scavenging capabilities. However, the in vivo application of Qu is limited by its poor water solubility and low bioavailability. These issues could be addressed by utilizing Qu nanoformulations. Cyclophosphamide (CP) is a potent chemotherapeutic agent that causes severe neuronal damage and cognitive impairment due to reactive oxygen species (ROS) overproduction. The present study aimed to explore the proposed neuroprotective mechanism of quercetin (Qu) and quercetin-loaded Chitosan nanoparticles (Qu-Ch NPs) against the brain oxidative damage induced by CP in male albino rats. For this aim, thirty-six adult male rats were randomly divided into six groups (n = 6). Rats were pretreated with Qu and Qu-Ch NPs orally in doses of 10 mg/kg bwt/day for 2 weeks, and CP (75 mg/kg bwt) was administered intraperitoneally 24 h before the termination of the experiment. After 2 weeks, some neurobehavioral parameters were evaluated, and then euthanization was done to collect the brain and blood samples. Results showed that CP induces neurobehavioral deteriorations and impaired brain neurochemical status demonstrated by a significant decrease in brain glutathione (GSH), serum total antioxidant capacity (TAC), and serotonin (5-HT) levels while malondialdehyde (MDA), nitric oxide (NO), Tumor necrosis factor α (TNFα), and choline esterase (ChE) concentrations increased significantly compared to the control group. Pretreatment with Qu and Qu-Ch NPs showed a significant anti-oxidative, anti-depressive, and neuroprotective effect through modification of the above-mentioned parameters. The results were further validated by assessing the expression levels of selected genes in brain homogenates and histopathological investigations were done to pinpoint the exact brain-altered regions. It could be concluded that Qu and Qu-Ch NPs can be useful neuroprotective adjunct therapy to overcome neurochemical damage induced by CP.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quercetina / Fármacos Neuroprotetores Limite: Animals Idioma: En Revista: Neurotoxicology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quercetina / Fármacos Neuroprotetores Limite: Animals Idioma: En Revista: Neurotoxicology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito